4.82
2.77%
0.13
시간 외 거래:
4.81
-0.01
-0.21%
전일 마감가:
$4.69
열려 있는:
$4.63
하루 거래량:
5.01M
Relative Volume:
1.21
시가총액:
$1.14B
수익:
$251.85M
순이익/손실:
$-72.58M
주가수익비율:
-40.17
EPS:
-0.12
순현금흐름:
$-63.80M
1주 성능:
-7.66%
1개월 성능:
-2.03%
6개월 성능:
-18.17%
1년 성능:
-18.86%
Ardelyx Inc Stock (ARDX) Company Profile
명칭
Ardelyx Inc
전화
510-745-7047
주소
34175 ARDENWOOD BLVD., FREMONT, CA
ARDX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
4.82 | 1.14B | 251.85M | -72.58M | -63.80M | -0.3134 |
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-11-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2024-07-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2024-04-05 | 개시 | Leerink Partners | Outperform |
2023-12-18 | 개시 | Raymond James | Strong Buy |
2023-09-07 | 개시 | H.C. Wainwright | Buy |
2023-08-25 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2023-03-03 | 업그레이드 | Wedbush | Neutral → Outperform |
2022-11-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2022-05-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
2021-12-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
2021-10-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
2021-07-21 | 다운그레이드 | Jefferies | Buy → Hold |
2021-07-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2021-07-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
2021-03-23 | 개시 | Wedbush | Outperform |
2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
2020-10-20 | 재개 | Citigroup | Buy |
2020-02-18 | 재개 | Jefferies | Buy |
2020-02-12 | 개시 | Citigroup | Buy |
2020-02-10 | 개시 | Cowen | Outperform |
2019-04-08 | 개시 | Piper Jaffray | Overweight |
2018-08-24 | 개시 | Jefferies | Buy |
2018-03-19 | 재개 | Leerink Partners | Outperform |
2017-11-29 | 재확인 | Citigroup | Buy |
2017-11-22 | 재확인 | Ladenburg Thalmann | Buy |
2017-10-17 | 재개 | Leerink Partners | Outperform |
2016-03-31 | 개시 | Ladenburg Thalmann | Buy |
2016-03-09 | 개시 | Cantor Fitzgerald | Buy |
2016-03-03 | 개시 | Citigroup | Buy |
모두보기
Ardelyx Inc 주식(ARDX)의 최신 뉴스
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Ardelyx: A Small Bet Its Latest Setback Will Be Temporary (NASDAQ:ARDX) - Seeking Alpha
Ardelyx stock hits 52-week low at $4.34 amid market challenges - Investing.com Canada
Ardelyx (NASDAQ:ARDX) Sets New 1-Year LowShould You Sell? - MarketBeat
Ardelyx (NASDAQ:ARDX) Shares Down 6.5%Here's What Happened - MarketBeat
State Street Corp Acquires 176,789 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - The Eastern Progress Online
Ardelyx, Inc. (NASDAQ:ARDX): Is Breakeven Near? - Yahoo Finance
Ardelyx (ARDX) Sees Its Depressed Stock Turning Around - TipRanks
Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - The Eastern Progress Online
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineARDX - The Eastern Progress Online
ARDX LAWSUIT ALERT: The Gross Law Firm Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - The Eastern Progress Online
Ardelyx, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts against Ardelyx, Inc - The Eastern Progress Online
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
Ardelyx CEO Michael Raab sells $131,620 in stock By Investing.com - Investing.com South Africa
Ardelyx CEO Michael Raab sells $131,620 in stock - Investing.com India
Ardelyx, Inc. (NASDAQ:ARDX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - The Eastern Progress Online
Faruqi & Faruqi Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - The Eastern Progress Online
Objective long/short (ARDX) Report - Stock Traders Daily
Hyperphosphatemia Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Ardelyx, Shield Therapeutics, Kyowa Kirin Co., Ltd., Shanghai Alebund Pharma, Sanofi, Bayer, Keryx - The Globe and Mail
Ardelyx, Inc. (NASDAQ:ARDX): Are Analysts Optimistic? - Simply Wall St
BNP Paribas Financial Markets Boosts Position in Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
Ardelyx, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsCXM - The Eastern Progress Online
Ardelyx FY2027 EPS Estimate Increased by Leerink Partnrs - MarketBeat
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit - The Eastern Progress Online
Ardelyx Inc (ARDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ardelyx Inc 주식 (ARDX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
RAAB MICHAEL | President & CEO |
Dec 10 '24 |
Sale |
5.26 |
25,000 |
131,620 |
1,150,385 |
자본화:
|
볼륨(24시간):